Published in Nature on October 27, 1977
Group-specific, major histocompatibility complex class I-restricted cytotoxic responses to human immunodeficiency virus 1 (HIV-1) envelope proteins by cloned peripheral blood T cells from an HIV-1-infected individual. Proc Natl Acad Sci U S A (1988) 2.30
HLA restriction of human cytotoxic T lymphocytes specific for influenza virus. Poor recognition of virus associated with HLA A2. J Exp Med (1978) 1.56
Friend virus-specific cytotoxic T lymphocytes recognize both gag and env gene-encoded specificities. J Exp Med (1986) 1.50
Nonrandom inclusion of H-2K and H-2D antigens in Friend virus particles from mice of various strains. J Exp Med (1978) 1.45
Multiplicity of virus-encoded helper T-cell epitopes expressed on FBL-3 tumor cells. J Virol (1993) 1.36
H-2D control of recovery from Friend virus leukemia: H-2D region influences the kinetics of the T lymphocyte response to Friend virus. J Exp Med (1983) 1.28
Quantitative differences in the expression of parentally-derived H-2 antigens in F1 hybrid mice affect T-cell responses. J Exp Med (1979) 1.12
Three spontaneous H-2Db mutants are generated by genetic micro-recombination (gene conversion) events. Impact on the H-2-restricted immune responsiveness. J Exp Med (1988) 1.08
Selective and unidirectional membrane redistribution of an H-2 antigen with an antibody-clustered viral antigen: relationship to mechanisms of cytotoxic T-cell interactions. Proc Natl Acad Sci U S A (1979) 1.02
Immune response genes control T killer cell response against Moloney tumor antigen cytolysis regulating reactions against the best available H-2 + viral antigen association. J Exp Med (1980) 0.96
Viral specificity of H-2-restricted T killer cells directed against syngeneic tumors induced by Gross, Friend, or Rauscher leukemia virus. J Exp Med (1979) 0.94
H-2D (Rfv-1) gene influence on recovery from Friend virus leukemia is mediated by nonleukemic cells of the spleen and bone marrow. J Exp Med (1980) 0.92
Possible cell surface receptor for Friend murine leukemia virus isolated with viral envelope glycoprotein complexes. J Virol (1980) 0.91
Persistence and pathogenicity of defective Friend spleen focus-forming virus. Decreased transplantability of hemopoietic cells as a marker for preleukemic change. J Exp Med (1979) 0.90
Isolation of human tumour-specific antigens associated with beta2 microglobulin. Br J Cancer (1978) 0.86
Role of endogenous alpha/beta interferon in the selection of virus nonproducer Friend leukemia cells after serial intraperitoneal passages in syngeneic mice. J Virol (1988) 0.83
Quantitative variations in the expression of H-2 antigens on murine leukemia virus-induced tumor cells can affect the H-2 restriction patterns of tumor-specific cytolytic T lymphocytes. J Exp Med (1981) 0.83
Lymphocytes. 1. Function. Genetic restrictions in the immune response. J Clin Pathol Suppl (R Coll Pathol) (1979) 0.76
Independence of chicken major histocompatibility antigens and tumor-associated antigen on the surface of herpesvirus-induced lymphoma cells. Infect Immun (1980) 0.75
Immunology of HIV infection and AIDS: memorandum from a WHO/IUIS meeting. Bull World Health Organ (1987) 0.75
Fv-2: identification and location of a second gene governing the spleen focus response to Friend leukemia virus in mice. J Natl Cancer Inst (1970) 6.08
A major genetic locus affecting resistance to infection with murine leukemia viruses. II. Apparent identity to a major locus described for resistance to friend murine leukemia virus. J Exp Med (1971) 5.50
FVB/N: an inbred mouse strain preferable for transgenic analyses. Proc Natl Acad Sci U S A (1991) 4.29
Susceptibility to two strains of Friend leukemia virus in mice. Science (1967) 4.12
Transmissible Agent Associated with 26 Types of Experimental Mouse Neoplasms. Science (1960) 3.50
Correlation of early murine leukemia virus titer and H-2 type with spontaneous leukemia in mice of the BALB/c times AKR cross: a genetic analysis. J Exp Med (1975) 2.98
The effect of histocompatibility-2 type on response to friend leukemia virus in mice. J Exp Med (1968) 2.57
The histocompatibility-2 locus and susceptibility to tumor induction. Natl Cancer Inst Monogr (1966) 2.48
The inheritance of susceptibility to the Gross leukemia virus in mice. Genetics (1966) 2.38
B-tropic Friend virus: a host-range pseudotype of spleen focus-forming virus (SFFV). Virology (1973) 2.34
Host control of endogenous murine leukemia virus gene expression: concentrations of viral proteins in high and low leukemia mouse strains. Proc Natl Acad Sci U S A (1974) 2.28
T-lymphocytes response to Friend virus-induced tumour cell lines in mice of strains congenic at H--2. Nature (1976) 1.99
Interactions between host and viral genomes in mouse leukemia. Annu Rev Genet (1977) 1.93
Selective incorporation of H-2 antigenic determinants into Friend virus particles. Nature (1977) 1.92
The role of genetics in Gross virus leukemogenesis. Bibl Haematol (1970) 1.86
Independence of H-2K and H-2D antigenic determinants on the surface of mouse lymphocytes. J Exp Med (1973) 1.76
A major genetic locus affecting resistance to infection with murine leukemia viruses. 3. Assignment of the Fv-1 locus to linkage group 8 of the mouse. J Exp Med (1973) 1.68
Properties of cell lines derived from tumors induced by Friend virus in BALB/c and BALB/c-H-2b mice. J Exp Med (1975) 1.55
Friend virus-specific cytotoxic T lymphocytes recognize both gag and env gene-encoded specificities. J Exp Med (1986) 1.50
Nonrandom inclusion of H-2K and H-2D antigens in Friend virus particles from mice of various strains. J Exp Med (1978) 1.45
Surface expression of a T cell receptor beta (TCR-beta) chain in the absence of TCR-alpha, -delta, and -gamma proteins. J Exp Med (1991) 1.39
Acceleration by thymosin of the development of resistance to murine sarcoma virus-induced tumor in mice. Proc Natl Acad Sci U S A (1970) 1.38
Activation of erythropoietin receptors by Friend viral gp55 and by erythropoietin and down-modulation by the murine Fv-2r resistance gene. Proc Natl Acad Sci U S A (1990) 1.33
Relation of chromosome 4 (linkage group 8) to murine leukemia virus-associated antigens of AKR mice. J Exp Med (1973) 1.27
FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens. J Exp Med (1989) 1.25
Fv-1 regulation of lymphoma development and of thymic ecotropic and xenotropic MuLV expression in mice of the AKR/J x RF/J cross. Cell (1978) 1.22
Antigens of murine leukemia viruses. Biochim Biophys Acta (1974) 1.19
Intracerebral hemorrhages and syncytium formation induced by endothelial cell infection with a murine leukemia virus. J Virol (1993) 1.14
The genetic basis of susceptibility to leukemia induction in mice by 3-methylcholanthrene applied percutaneously. J Exp Med (1978) 1.14
Viral protein expression in producer and nonproducer clones of friend erythroleukemia cell lines. J Virol (1981) 1.12
Maternally transmitted resistance to lymphoma development in mice of reciprocal crosses of the RF/J and AKR/J strains. Cell (1980) 1.11
Mechanisms of the H-2 effect on viral leukemogenesis. Scand J Immunol (1977) 1.09
Genetic control of the expression of murine leukemia virus proteins in tissues of normal, young adult mice. Cold Spring Harb Symp Quant Biol (1975) 1.07
Identification of an epitope encoded in the env gene of Friend murine leukemia virus recognized by anti-Friend virus cytotoxic T lymphocytes. Virology (1991) 1.04
Effect of interferon on thoracic duct lymphocyte output: induction with either poly I:poly C or vaccinia virus. J Immunol (1983) 1.04
Cell surface antigen induced by Friend murine leukemia virus is also in the virion. J Virol (1974) 1.03
Suppression of spontaneous lymphoma by previously undiscovered dominant genes in crosses of high- and low-incidence mouse strains. Virology (1982) 1.02
Inhibition of macrophage-induced antigen-specific T-cell proliferation by interferon-gamma. Cell Immunol (1988) 1.02
Genetic control of the antibody response to the H-2.2 alloantigen in mice. Transplant Proc (1973) 1.02
A role for complement receptor-like molecules in iron acquisition by Candida albicans. J Exp Med (1992) 1.00
Genetic regulation of the antibody response to H-2Db alloantigens in mice. I. Differences in activation of helper T cells in C57BL/10 and BALB/c congenic strains. J Exp Med (1975) 0.99
Mouse leukemia: a model of a multiple-gene disease. J Natl Cancer Inst (1972) 0.99
Studies on the FMR antigen. Transplant Proc (1969) 0.99
Genetic and nongenetic factors in expression of infectious murine leukemia viruses in mice of the DBA/2 x RF cross. Cell (1980) 0.98
Tumors induced by murine sarcoma virus contain precursor cells capable of generating tumor-specific cytolytic T lymphocytes. J Exp Med (1979) 0.98
Variations in viral gene expression in Friend virus-transformed cell lines congenic with respect to the H-2 locus. Cell (1978) 0.97
Antigenic properties of cultured tumor cell lines derived from spleens of Friend virus-infected BALB/c and BALB/c-H-2b mice. J Exp Med (1975) 0.97
Protection against murine disseminated candidiasis mediated by a Candida albicans-specific T-cell line. Infect Immun (1993) 0.96
Loss of antigenic epitopes as the result of env gene recombination in retrovirus-induced leukemia in immunocompetent mice. Virology (1993) 0.94
Interim report of the Presidential Commission on the Human Immunodeficiency Virus Epidemic: Chairman's recommendations--Part I. J Acquir Immune Defic Syndr (1988) 0.94
Viral specificity of H-2-restricted T killer cells directed against syngeneic tumors induced by Gross, Friend, or Rauscher leukemia virus. J Exp Med (1979) 0.94
Origin of spleen colonies generated by Friend virus-infected cells in mice. Cancer Res (1978) 0.93
Suppression of H-2b-associated resistance to Friend erythroleukemia virus by a class I gene from the H-2d major histocompatibility complex haplotype. Proc Natl Acad Sci U S A (1991) 0.92
Characterization of a new intra-H-2 recombinant separation of the Ir-RE and Ir-GLT genes. J Exp Med (1974) 0.92
T cell receptor genes and T cell development in virus-transformed early T cell lines. J Immunol (1990) 0.91
Suppression of endogenous murine leukemia virus by maternal resistance factor. J Exp Med (1983) 0.91
Influence of histoincompatibility between mother and foetus on placental size in mice. Nature (1971) 0.90
Reversal by thymosin of increased susceptibility of immunosuppressed mice to Moloney sarcoma virus. Transplant Proc (1971) 0.89
Studies of cloned Friend erythroleukemia tumor cells. Modulation of the tumor-specific cytologic T lymphocyte response by infectious Friend virus production in vitro. J Exp Med (1980) 0.89
Neonatal exposure to thymotropic gross murine leukemia virus induces virus-specific immunologic nonresponsiveness. J Exp Med (1990) 0.88
Comparison of endogenous murine leukemia virus proviral organization and RNA expression in 3-methylcholanthrene-induced and spontaneous thymic lymphomas in RF and AKR mice. J Virol (1985) 0.88
Genetically determined resistance to 3-methylcholanthrene-induced lymphoma is expressed at the level of bone marrow-derived cells. J Exp Med (1987) 0.87
Expression of differentiation and murine leukemia virus antigens on cells of primary tumors and cell lines derived from chemically induced lymphomas of RF/J mice. Proc Natl Acad Sci U S A (1984) 0.87
The Fv-2r resistance gene in mice: its effect on spleen colony formation by Friend virus-transformed cells. J Natl Cancer Inst (1976) 0.87
Expression of viral RNA in Friend virus-induced erythroleukemia cells. Cell (1980) 0.87
Microsatellite typing of CXB recombinant inbred and parental mouse strains. Mamm Genome (1997) 0.86
Effect of Friend leukemia virus infection on susceptibility to Candida albicans. Infect Immun (1990) 0.85
Genetically dominant resistance in mice to 3-methylcholanthrene-induced lymphoma. Proc Natl Acad Sci U S A (1980) 0.85
Interferon-gamma, interferon-alpha/beta, and tumor necrosis factor differentially affect major histocompatibility complex class I expression in murine leukemia virus-induced tumor cell lines. J Immunol (1987) 0.85
Environmental lighting alters the infection process in an animal model of AIDS. Pharmacol Biochem Behav (1995) 0.85
Construction of a D2.B6-Fv-2r congenic mouse strain: nonlethality of the homozygous Fv-2' genotype. J Natl Cancer Inst (1981) 0.85
Approach to a retrovirus vaccine: immunization of mice against Friend virus disease with a replication-defective Friend murine leukemia virus. Proc Natl Acad Sci U S A (1992) 0.85
Genetic basis for protection against experimental vaginal candidiasis by peripheral immunization. J Infect Dis (1998) 0.84
Quantitative variations in the expression of H-2 antigens on murine leukemia virus-induced tumor cells can affect the H-2 restriction patterns of tumor-specific cytolytic T lymphocytes. J Exp Med (1981) 0.83
Fv-2r-mediated resistance of mouse bone-marrow cells to Friend spleen focus-forming virus infecton. Int J Cancer (1980) 0.83
Evidence that endogenous ecotropic virus is not expressed in AKR thymic lymphoid cells of chimeric hosts. J Exp Med (1980) 0.83
Poly I:C or IFN-alpha/beta treatment inhibits macrophage induced T cell proliferation. J Interferon Res (1985) 0.82
Combined neoplastic effects of vaccinia virus and 3-methylcholanthrene. II. Genetic factors. J Natl Cancer Inst (1972) 0.82
Genetic factors in susceptibility to viral leukemogenesis. Prog Med Virol (1985) 0.82
Genetic regulation of the antibody response to H-2Db alloantigens in mice. II. Tolerance to non-H-2 determinants abolishes the antibody response to H-2Db in B10.A(5R) mice. J Exp Med (1976) 0.82
Variation in RNA tumor virus expression in H-2 congenic leukemia cell lines. Immunogenetics (1981) 0.81
Combined neoplastic effects of vaccinia virus and 3-methylcholanthrene. 3. Susceptibility and resistance in transplanted mouse skin. J Natl Cancer Inst (1973) 0.81
Infection and transformation of Fv-2rr erythroprogenitor cells with Friend virus. Virus Res (1987) 0.81
Use of hybridoma-resident variant cell lines to study H-2Db/FMR-specific cytotoxic T cells. Immunogenetics (1981) 0.80
In vivo generation of antigenic variants of murine retroviruses. Virology (1989) 0.80
Direct involvement of the CDR3-like domain of CD4 in T helper cell activation. J Immunol (1992) 0.80
The influence of genetic background on the susceptibility of inbred mice to streptozotocin-induced diabetes. Diabetes (1984) 0.80
Specific infection of central nervous system white matter by a variant of gross murine leukemia virus. Virology (1990) 0.80
Anti-Friend virus antibody-induced resistance of Friend virus-infected spleen cells to lysis mediated by anti-H-2 antisera. Cancer Res (1978) 0.80
A murine leukemia virus expressed in aged DBA/2 mice is derived by recombination of the Emv-3 locus and another endogenous gag sequence. Virology (1994) 0.80
Genetic regulation of the antibody response to H-2Db alloantigens in mice. III. Inhibition of the IgG Response to noncongenic cells by preimmunization with congenic cells. J Exp Med (1976) 0.80
Characterization of cell lines derived from enlarged spleens induced in C57BL/6 mice by the variant BSB strain of Friend erythroleukemia virus. Virus Res (1987) 0.79
Chemically induced murine T lymphomas: continued rearrangement within the T-cell receptor beta-chain gene during serial passage. Proc Natl Acad Sci U S A (1988) 0.79
Identification of a variant of gross leukemia virus that induces disease in mice inoculated as adults. J Exp Med (1983) 0.79
Induction of anti-MuLV cytotoxic T lymphocytes in the AKR.H-2b and AKR.H-2b:Fv-1b mouse strains. Cell Immunol (1988) 0.79
Altered macrophage antigen-presenting cell function following Friend leukemia virus infection. Viral Immunol (1992) 0.79